Wavelens · Project

Next-Gen Microscope Lens That Sees Deep Into Living Tissue

healthPrototypeTRL 5

Imagine trying to look through a frosted glass window — that's what happens when doctors and scientists try to image deep inside living tissue with a regular microscope. Light scatters and everything gets blurry. Wavelens figured out how to pre-shape the light beam so it cuts through the scattering, like knowing exactly how to angle your flashlight to see clearly through fog. They packaged this trick into something that fits right onto a standard microscope, replacing the normal lens with a smart one that adapts in real time.

By the numbers

Demonstrator prototypes built (transmission and reflection geometry)

EUR 100,000

EU contribution for commercialization preparation

Research partner (single-coordinator project)

Total project deliverables

The business problem

What needed solving

Current optical microscopes hit a hard depth limit in biological tissue — light scatters and resolution collapses within the first few hundred microns. This forces researchers and quality inspectors to physically slice samples, destroying them and slowing workflows. Companies doing biological imaging, drug development, or tissue inspection are stuck choosing between destructive sample prep or blurry deep images.

The solution

What was built

Two demonstrator prototypes: one for transmission geometry and one for reflection geometry, both integrating adaptive wavefront shaping into a standard microscope objective lens form factor. The project also produced a market analysis, IP valuation, and business plan for a potential spin-off company.

Audience

Who needs this

Microscope manufacturers (Zeiss, Leica, Olympus, Nikon)Pharmaceutical companies running high-content imaging screensPathology and histology labs in hospitalsBiotech startups doing 3D tissue or organoid imagingSemiconductor inspection equipment makers

Business applications

Who can put this to work

Microscope & Optical Instrument Manufacturing

enterprise

Target: Microscope OEMs like Zeiss, Leica, Nikon, or Olympus

If you are a microscope manufacturer looking for your next premium product line — this project developed 2 demonstrator prototypes of an adaptive wavefront shaping objective lens that drops into a standard microscope body. It extends usable imaging depth in biological tissue without requiring entirely new platform designs, giving you a competitive edge in the growing life-science imaging market.

Pharmaceutical & Biotech

enterprise

Target: Pharma companies with high-content screening or tissue imaging labs

If you are a pharma R&D team struggling with destructive sample preparation for deep tissue imaging — this project built a lens that sees deeper into living tissue non-invasively. With 2 working prototypes already demonstrated, this could reduce your sample prep time and let you image 3D tissue models and organoids without slicing them.

Clinical Pathology & Diagnostics

any

Target: Hospital pathology departments or diagnostic imaging companies

If you are a pathology lab spending time on physical tissue sectioning and staining to get clear microscope images — this adaptive lens technology could let you inspect tissue samples at greater depth without cutting. The project delivered prototypes in both transmission and reflection geometry, meaning it can adapt to different clinical imaging setups.

Frequently asked

Quick answers

What would licensing or purchasing this technology cost?

The project had a total EU contribution of EUR 100,000 as a Coordination and Support Action, which funded commercialization exploration rather than heavy R&D. Licensing terms would need to be negotiated directly with the coordinator. The project completed an IP valuation and business plan, so pricing groundwork exists.

Can this scale to industrial production volumes?

The current state is 2 demonstrator prototypes — one in transmission and one in reflection geometry. Scaling to production would require engineering for manufacturability, which has not yet been done within this project. A manufacturing partner or spin-off company would be needed to bridge that gap.

What is the IP situation — can I license this?

The project explicitly conducted IP valuation and freedom-to-operate analysis as part of its objectives. The technology sits with the coordinator IDRYMA TECHNOLOGIAS KAI EREVNAS in Greece, a public research foundation. Licensing or spin-off partnership discussions would start there.

How does this integrate with existing microscopes?

A key design goal was to fit the adaptive wavefront shaping system into the shell of a standard microscope objective lens. This means it is intended as a drop-in replacement, not a separate platform. Both demonstrator prototypes were built with this integration approach.

What is the current development stage?

The project delivered 2 demonstrator prototypes and completed a market analysis, IP valuation, and business plan. It was explicitly a commercialization preparation project linked to the earlier DynAMic research project. Based on available project data, the technology is at proof-of-concept to early demonstrator stage.

Is there regulatory approval needed?

For research and industrial inspection use, no specific medical device approval would be needed. If used in clinical diagnostics, the lens system would likely need to be part of a certified medical device. Based on available project data, regulatory pathways were not explicitly addressed.

Consortium

Who built it

This is a single-partner project run entirely by IDRYMA TECHNOLOGIAS KAI EREVNAS (FORTH), a well-known Greek research foundation. With 0 industry partners and 0 SMEs in the consortium, there is no built-in commercial pathway or manufacturing capability. The EUR 100,000 budget and CSA funding type confirm this was a commercialization exploration exercise — mapping the market, valuing IP, and building a business plan — rather than a full product development effort. For a business considering this technology, the absence of industry partners means the door is wide open for a first-mover licensing or spin-off partnership, but it also means significant engineering and manufacturing work remains before a market-ready product.

IDRYMA TECHNOLOGIAS KAI EREVNASCoordinator · EL

How to reach the team

The coordinator is FORTH (Foundation for Research and Technology - Hellas) in Greece. Use SciTransfer's coordinator lookup service to get the right contact.

Order a report on this consortium See IDRYMA TECHNOLOGIAS KAI EREVNAS profile →

Next steps

Talk to the team behind this work.

Want an introduction to the Wavelens team? SciTransfer can connect you with the researchers and provide a detailed technology brief tailored to your use case.

Order a report on this topic More in Health & Biomedical